BIOLOGICAL DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS: REAL LIFE DATA IN A BRAZILIAN MULTICENTRIC STUDY

被引：0
|
作者：
Gomides, A. [1 ]
Pinheiro, G. [2 ]
Santos, A. [2 ]
Albuquerque, C. [3 ]
Giorgi, R. [4 ]
Radominski, S. [5 ]
Pereira, I. [6 ]
Guimaraes, M. [7 ]
Bertolo, M. [8 ]
Junior, P. L. [9 ]
Bonfiglioli, K. [10 ]
Brenol, C. [11 ]
Cunha, M. [12 ]
Mota, L. [3 ]
机构：
[1] Univ Brasilla, UnB Brasil, Brasilia, DF, Brazil
[2] Univ Estado Rio de Janeiro, Rio De Janeiro, Brazil
[3] Univ Brasilia, Brasilia, DF, Brazil
[4] Inst Assistencia Med Servidor Publ Estadual, Sao Paulo, Brazil
[5] Univ Fed Parana, Curitiba, Parana, Brazil
[6] Univ Fed Santa Catarina, Florianopolis, SC, Brazil
[7] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[8] Univ Estadual Campinas, Campinas, SP, Brazil
[9] Univ Sao Paulo Ribeirao Preto, Ribeirao Preto, Brazil
[10] Univ Sao Paulo, Sao Paulo, Brazil
[11] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
[12] Univ Fed Para, Belem, Para, Brazil
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.7090
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0417
引用
收藏
页码：1372 / 1373
页数：3
相关论文
共 50 条
  • [1] Expenditure of biological drugs for rheumatoid arthritis treatment in the Brazilian health
    Mega, Tacila Pires
    da Silva, Rondineli Mendes
    REVISTA DE SAUDE PUBLICA, 2023, 57
  • [2] Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs ‘in’ rheumatoid arthritis
    Ana Paula Monteiro Gomides
    Cleandro Pires de Albuquerque
    Ana Beatriz Vargas Santos
    Manoel Barros Bértolo
    Paulo Louzada Júnior
    Rina Dalva Neubarth Giorgi
    Sebastião Cezar Radominski
    Maria Fernanda B. Resende Guimarães
    Karina Rossi Bonfiglioli
    Maria de Fátima Lobato da Cunha Sauma
    Ivânio Alves Pereira
    Claiton Viegas Brenol
    Licia Maria Henrique da Mota
    Geraldo da Rocha Castelar Pinheiro
    International Journal of Clinical Pharmacy, 2021, 43 : 737 - 742
  • [3] Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs 'in' rheumatoid arthritis
    Gomides, Ana Paula Monteiro
    de Albuquerque, Cleandro Pires
    Santos, Ana Beatriz Vargas
    Bertolo, Manoel Barros
    Junior, Paulo Louzada
    Giorgi, Rina Dalva Neubarth
    Radominski, Sebastiao Cezar
    Resende Guimaraes, Maria Fernanda B.
    Bonfiglioli, Karina Rossi
    de Fatima Lobato da Cunha Sauma, Maria
    Pereira, Ivanio Alves
    Brenol, Claiton Viegas
    da Mota, Licia Maria Henrique
    Pinheiro, Geraldo da Rocha Castelar
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (03) : 737 - 742
  • [4] COSTS OF TREATMENT OF RHEUMATOID ARTHRITIS WITH BIOLOGICAL DRUGS
    Rasmussen, C.
    Knudsen, M. S.
    Hansen, B. B.
    Lindkvist, R. M.
    VALUE IN HEALTH, 2008, 11 (06) : A541 - A541
  • [5] Biological Treatment for Rheumatoid Arthritis (RA): A Fifteen Years Multicentric Overview
    Grosso, Vittorio
    Gorla, Roberto
    Sarzi-Puttini, Piercarlo
    Atzeni, Fabiola
    Pellerito, Raffaele
    Fusaro, Enrico
    Paolazzi, Giuseppe
    Rocchetta, Pier Andrea
    Favalli, Ennio Giulio
    Marchesoni, Antonio
    Caporali, Roberto
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1098 - S1099
  • [6] The Economic Burden of Biological Drugs in Rheumatoid Arthritis Treatment
    Grega, Dominik
    Kolar, Jozef
    VALUE IN HEALTH REGIONAL ISSUES, 2024, 40 : 13 - 18
  • [7] Effects of Conventional and Biological Drugs Used for the Treatment of Rheumatoid Arthritis on the Quality of Life and Depression
    Ilker-Yayikci, Yakup
    Karadag, Ahmet
    EURASIAN JOURNAL OF MEDICINE, 2019, 51 (01): : 12 - 16
  • [8] SWITCHING RATE OF BIOLOGICAL DMARDS IN RHEUMATOID ARTHRITIS PATIENTS: TREASURE REAL LIFE DATA
    Kalyoncu, Umut
    Ertenli, Ali Ihsan
    Erden, Abdulsamet
    Kucuksahin, Orhan
    Kasifoglu, Timucin
    Dalkilic, Ediz
    Bes, Cemal
    Kanitez, Nilufer Alpay
    Emmungil, Hakan
    Atagunduz, Pamir
    Coskun, Belkis Nihan
    Yagiz, Burcu
    Koca, Suleyman Serdar
    Cinar, Muhammet
    Ates, Askin
    Akar, Servet
    Gercik, Onay
    Ersozlu, Duygu
    Yazisiz, Veli
    Kimyon, Gezmis
    Aydin, Muge
    Mercan, Ridvan
    Oz, Burak
    Bilge, Nazife Sule Yasar
    Akar, Zeynel Abidin
    Karadag, Omer
    Dincer, Ayse Bahar Kelesoglu
    Yilmaz, Sedat
    Ilgen, Ufuk
    Pehlivan, Yavuz
    Terzioglu, Ender
    Kilic, Levent
    Erten, Sukran
    Kiraz, Sedat
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 713 - 714
  • [9] REAL LIFE SEVERE INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON TREATMENT WITH BIOLOGICAL THERAPY AND JAKI
    Vega, L.
    Calvo, I.
    Ibarguengoitia, O.
    Montero, D.
    Garcia, C.
    Blanco, J. M.
    Ruiz, M. E.
    Inchaurbe, A. R.
    Torre, I.
    Perez, C. E.
    Fernandez, O.
    Cuande, E.
    Exposito-Molinero, M. R.
    Gorostiza, I.
    Vivar, M. L. Garcia
    Galindez, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1104 - 1104
  • [10] REAL LIFE SEVERE INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON TREATMENT WITH BIOLOGICAL THERAPY AND JAKI
    Vega, L.
    Calvo, I.
    Ibarguengoitia, O.
    Blanco, J. M.
    Montero, D.
    Garcia, C.
    Ruiz, M. E.
    Inchaurbe, A. R.
    Torre, I.
    Perez, C. E.
    Fernandez, O.
    Cuande, E.
    Gorostiza, I.
    Garcia Vivar, M. L.
    Galindez, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 977 - 977
12345